Your needs are our needs

We’re developing our own cell therapy to treat Type 1 Diabetes, so our assays have been developed to meet international manufacturing and clinical monitoring regulations from the outset.

Because we share the same needs, we understand yours better than most.

We can provide a range of analytical and molecular diagnostic services using predominantly molecular methodologies that provide accuracy, quantitation and speed of result that your advanced therapeutic medical products require. 

We innovate for you

We are committed to keeping pace with your innovation and introducing rapid analytical and diagnostic methods into your manufacturing and clinical development that go beyond slow, outdated methods and are validated to US, EU and British regulatory requirements and pharmacopoeia standards.

We go further.

When you need to go beyond the norm, we offer you the opportunity to expediently and cost effectively develop validated assays that are specific to your product’s manufacturing and clinical needs

  • Biosafety

    RAPID sterility

    Endotoxin

    Adventitious agents

    Mycoplasma

    Residual contaminants

  • Viral & Cell Therapies

    RCV detection

    Viral insert copy #

    Residual contaminants

  • Xenotransplantation

    DPF herd establishment & monitoring.

    PERV screening.

    Zoonotic viruses, fungi, parasites